The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association.

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

In his lifetime, Luther Vandross was nominated for 31 Grammy awards, winning eight. He dominated the R&B charts and wedding ...

The actor says cutting his diet to two foods has transformed his life and left him pain free from his debilitating arthritis ...

Concern about unsafe prescribing of weight-loss jabs has led to stricter guidance for online pharmacies, thanks to the General Pharmaceutical Council (GPhC). Online pharmacies must now use in ...

An app that helps people and teams in the working world simplify their to-do lists — ideally by organizing and doing some of the work for them ... out a knowledge graph,” said CEO Tarjei ...

Conclusion: In patients with severe obesity who completed a milk-based meal replacement programme and lost a large amount of weight, over 4 years of follow-up there was very substantial weight regain.